Synonym(s)
beta-interferon-1b; IFN β-1b; IFN-β-1b; interferon-beta-1b; Interferon-β-1b; β-Interferon-1b
DefinitionThis section has been translated automatically.
IndicationThis section has been translated automatically.
Multiple sclerosis characterized by 2 or more relapses within the last 2 years.
You might also be interested in
Limited indicationThis section has been translated automatically.
Severe kidney and liver damage, severe myelosuppression.
Pregnancy/nursing periodThis section has been translated automatically.
Contraindicated.
Dosage and method of useThis section has been translated automatically.
0,25 mg (8 million IU) every second day s.c.
Undesirable effectsThis section has been translated automatically.
Rare but strong acute reactions like bronchospasm, anaphylaxis, urticaria. Frequently flu-like general symptoms (fever, fatigue, chills, headaches, myalgia, sweating), reactions at the injection site (erythema).
InteractionsThis section has been translated automatically.
Comedication with effect on hematopoiesis, antidepressants.
ContraindicationThis section has been translated automatically.
Pat. < 18 years, severe depression, suicidal tendency, epilepsy with seizures that cannot be sufficiently controlled therapeutically, liver failure.
PreparationsThis section has been translated automatically.
Betaferon
Note(s)This section has been translated automatically.
Remember! No use together with other immunomodulators except glucocorticoids or ACTH. Caution with comedication with interferon beta-1b and substances which are primarily metabolized by the cytochrome P450 system (e.g. antiepileptic drugs).
Prof. Dr. med. Peter Altmeyer